Novo cuts Ozempic, Wegovy prices up to 48% as generics surge
Novo Nordisk cut prices for its diabetes and weight-loss injections Ozempic and Wegovy in India on Tuesday, marking a second reduction aimed at countering cheaper local generics. The company lowered list prices by up to 36% for Ozempic and up to 48% for Wegovy, with the move following the March 20 expiry of India’s patent
